Published by Iain Gilbert on 10th April 2025
(Sharecast News) - Precision medicine business Renalytix said on Thursday that Q3 trading was in line with expectations, delivering 20% quarter-on-quarter revenue growth as it reached "the key milestone" of processing over 1,000 billable tests within the quarter for the first time.
URL: http://www.digitallook.com/dl/news/story/35005409/...